newsfilter
← Latest News
Business Wire·

Immunome to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at Guggenheim's Emerging